P. Parini et al., Cholesterol and lipoprotein metabolism in aging - Reversal of hypercholesterolemia by growth hormone treatment in old rats, ART THROM V, 19(4), 1999, pp. 832-839
Plasma cholesterol levels increase with age, as does the incidence of coron
ary heart disease. The mechanisms responsible for the age-related hyperchol
esterolemia are not well understood. An interesting hypothesis suggests tha
t the relative deficiency in growth hormone (GH), which occurs with aging,
contributes to the development of the age-related hypercholesterolemia, bec
ause GH has beneficial effects on cholesterol metabolism. In the present wo
rk, we tested this hypothesis by the administration of GH to normal rats of
varying ages. Plasma lipids and hepatic cholesterol metabolism were charac
terized in 2-, 12-, and Is-month-old male Sprague-Dawley rats. In 2-month-o
ld rats, GH specifically stimulated the hepatic low density lipoprotein (LD
L) receptor expression in a dose-dependent way, both at the protein level a
nd at the mRNA level. Concomitantly, plasma cholesterol increased by approx
imate to 30% within the large high density lipoprotein and LDL fractions. I
n 12-month-old animals, cholesterol 7 alpha-hydroxylase (C7 alpha OH) activ
ity was reduced, whereas hepatic LDL receptors and plasma total cholesterol
were unchanged. GH treatment (1 mg kg(-1) d(-1)) normalized the activity o
f C7 alpha OH and had effects on plasma cholesterol and LDL receptors simil
ar to these seen In 2-month-old animals. In 18-month-old rats, plasma chole
sterol was increased 2-fold, whereas hepatic LDL receptor expression and C7
alpha OH activity were similar to those of the 12-month-old animals. Infus
ion of CH to 18-month-old rats had similar effects on hepatic C7 alpha OH a
nd LDL receptors as seen in 12-month-old rats. However, GH treatment strong
ly reduced the hypercholesterolemia in 18-month-old animals. We conclude th
at the age-dependent increase of plasma cholesterol in rats can be reversed
by the administration of GH, presumably through the pleiotropic effects of
this hormone on Lipoprotein metabolism.